Peptide record

TPDB02380

Antibacterial Anticancer Antifungal Antiparasitic Antiviral Cell-penetrating Peptides Hemolysis Toxicity standard
10 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB02380
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Cell-penetrating Peptides Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides Delivery and barrier-penetrating peptides
AntiBP3 dbAMP DRAMP Peptipedia AntiCP 2.0 iACP-DRLF CAFPdb i2APP AVPpred-BWR CellPPD-MOD APD_complete PD_Hemolysis ToxinPred 3.0
standard
No
A 10-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GLLKRIKTLL
Physicochemical Analysis
C54H103N15O12
ANDCEQHMFPSWYV
L
1154.51
11.64
3
0
5
+3
0.39
0.630
195.00
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
1
Residue Composition
number
0
A
1
R
0
N
0
D
0
C
0
E
0
Q
1
G
0
H
1
I
4
L
2
K
0
M
0
F
0
P
0
S
1
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 1 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 1 H: 0 I: 1 L: 4 K: 2 M: 0 F: 0 P: 0 S: 0 T: 1 W: 0 Y: 0 V: 0
Chemical Descriptors
10
C54H103N15O12
1154.51
11.64
+3
0.39
0.630
Evidence Records 54 records
Evidence 1 Activity

Activity

0% Hemolysis
Toxicity
100 µg/mL
Hemolytic Cytotoxic
0% Hemolysis | 100 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Synthesis and biological activity of lipophilic analogs of the cationic antimicrobial active peptide anoplin. | J Pept Sci | 2016
Evidence 2 Activity

Activity

8% Hemolysis
Toxicity
200 µg/mL
Hemolytic Cytotoxic
8% Hemolysis | 200 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Synthesis and biological activity of lipophilic analogs of the cationic antimicrobial active peptide anoplin. | J Pept Sci | 2016
Evidence 3 Activity

Activity

10% Hemolysis
Toxicity
300-500 µg/mL
Hemolytic Cytotoxic
10% Hemolysis | 300-500 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Synthesis and biological activity of lipophilic analogs of the cationic antimicrobial active peptide anoplin. | J Pept Sci | 2016
Evidence 4 Activity

Activity

10% Hemolysis
Toxicity
210.63 µM
Hemolytic Cytotoxic
10% Hemolysis | 210.63 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 5 Activity

Activity

IC50
Toxicity
>256 µM
Cytotoxic
IC50 | >256 | µM | target cell: Human glomerular mesangial cells (GMC)

Target

Human glomerular mesangial cells (GMC)

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 6 Activity

Activity

10% Hemolysis
Toxicity
11.38 µM
Hemolytic Cytotoxic
10% Hemolysis | 11.38 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 7 Activity

Activity

10% Hemolysis
Toxicity
>256 µM
Hemolytic Cytotoxic
10% Hemolysis | >256 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 8 Activity

Activity

50% Hemolysis
Toxicity
2407.73 µM
Hemolytic Cytotoxic
50% Hemolysis | 2407.73 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Evidence 9 Activity

Activity

50% Hemolysis
Toxicity
>500 µg/mL
Hemolytic Cytotoxic
50% Hemolysis | >500 | µg/mL | target cell: Sheep erythrocytes

Target

Sheep erythrocytes

Source & Reference

NA
DBAASP
Improving the biological activity of the antimicrobial peptide anoplin by membrane anchoring through a lipophilic amino acid derivative. | Bioorg Med Chem Lett | 2013
Evidence 10 Activity

Activity

10% Hemolysis
Toxicity
>64 µM
Hemolytic Cytotoxic
10% Hemolysis | >64 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Improved bioactivity of antimicrobial peptides by addition of amino-terminal copper and nickel (ATCUN) binding motifs. | ChemMedChem | 2014
Evidence 11 Activity

Activity

30% Hemolysis
Toxicity
32 µM
Hemolytic Cytotoxic
30% Hemolysis | 32 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Copper-binding tripeptide motif increases potency of the antimicrobial peptide Anoplin via Reactive Oxygen Species generation. | Biochem Biophys Res Commun | 2015
Evidence 12 Activity

Activity

10% Hemolysis
Toxicity
>256 µM
Hemolytic Cytotoxic
10% Hemolysis | >256 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Design and synthesis of new N-terminal fatty acid modified-antimicrobial peptide analogues with potent in vitro biological activity. | Eur J Med Chem | 2019
Evidence 13 Activity

Activity

10% Hemolysis
Toxicity
256 µM
Hemolytic Cytotoxic
10% Hemolysis | 256 | µM | target cell: Mouse erythrocytes

Target

Mouse erythrocytes

Source & Reference

NA
DBAASP
Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria. | Eur J Pharm Sci | 2020
Evidence 14 Activity

Activity

IC50
Toxicity
>256 µM
Cytotoxic
IC50 | >256 | µM | target cell: Human embryonic kidney HEK293T cells

Target

Human embryonic kidney HEK293T cells

Source & Reference

NA
DBAASP
Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria. | Eur J Pharm Sci | 2020
Evidence 15 Activity

Activity

50% Hemolysis
Toxicity
5 µg/mL
Hemolytic Cytotoxic
50% Hemolysis | 5 | µg/mL | target cell: Sheep erythrocytes

Target

Sheep erythrocytes

Source & Reference

NA
DBAASP
Improving the biological activity of the antimicrobial peptide anoplin by membrane anchoring through a lipophilic amino acid derivative. | Bioorg Med Chem Lett | 2013
Evidence 16 Activity

Activity

10% Hemolysis
Toxicity
100-500 µg/mL
Hemolytic Cytotoxic
10% Hemolysis | 100-500 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Synthesis and biological activity of lipophilic analogs of the cationic antimicrobial active peptide anoplin. | J Pept Sci | 2016
Evidence 17 Activity

Activity

10% Hemolysis
Toxicity
16.36 µM
Hemolytic Cytotoxic
10% Hemolysis | 16.36 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 18 Activity

Activity

IC50
Toxicity
184.55 µM
Cytotoxic
IC50 | 184.55 | µM | target cell: Human glomerular mesangial cells (GMC)

Target

Human glomerular mesangial cells (GMC)

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 19 Activity

Activity

10% Hemolysis
Toxicity
51.2 µM
Hemolytic Cytotoxic
10% Hemolysis | 51.2 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 20 Activity

Activity

IC50
Toxicity
61.89 µM
Cytotoxic
IC50 | 61.89 | µM | target cell: Human glomerular mesangial cells (GMC)

Target

Human glomerular mesangial cells (GMC)

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 21 Activity

Activity

10% Hemolysis
Toxicity
27.61 µM
Hemolytic Cytotoxic
10% Hemolysis | 27.61 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 22 Activity

Activity

IC50
Toxicity
58.22 µM
Cytotoxic
IC50 | 58.22 | µM | target cell: Human glomerular mesangial cells (GMC)

Target

Human glomerular mesangial cells (GMC)

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 23 Activity

Activity

10% Hemolysis
Toxicity
6.08 µM
Hemolytic Cytotoxic
10% Hemolysis | 6.08 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 24 Activity

Activity

IC50
Toxicity
42.73 µM
Cytotoxic
IC50 | 42.73 | µM | target cell: Human glomerular mesangial cells (GMC)

Target

Human glomerular mesangial cells (GMC)

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 25 Activity

Activity

10% Hemolysis
Toxicity
5.67 µM
Hemolytic Cytotoxic
10% Hemolysis | 5.67 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 26 Activity

Activity

IC50
Toxicity
29.43 µM
Cytotoxic
IC50 | 29.43 | µM | target cell: Human glomerular mesangial cells (GMC)

Target

Human glomerular mesangial cells (GMC)

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 27 Activity

Activity

10% Hemolysis
Toxicity
26.56 µM
Hemolytic Cytotoxic
10% Hemolysis | 26.56 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 28 Activity

Activity

IC50
Toxicity
57.69 µM
Cytotoxic
IC50 | 57.69 | µM | target cell: Human glomerular mesangial cells (GMC)

Target

Human glomerular mesangial cells (GMC)

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 29 Activity

Activity

10% Hemolysis
Toxicity
15.16 µM
Hemolytic Cytotoxic
10% Hemolysis | 15.16 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 30 Activity

Activity

IC50
Toxicity
102.13 µM
Cytotoxic
IC50 | 102.13 | µM | target cell: Human glomerular mesangial cells (GMC)

Target

Human glomerular mesangial cells (GMC)

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 31 Activity

Activity

10% Hemolysis
Toxicity
2.53 µM
Hemolytic Cytotoxic
10% Hemolysis | 2.53 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 32 Activity

Activity

IC50
Toxicity
3.73 µM
Cytotoxic
IC50 | 3.73 | µM | target cell: Human glomerular mesangial cells (GMC)

Target

Human glomerular mesangial cells (GMC)

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 33 Activity

Activity

10% Hemolysis
Toxicity
3.18 µM
Hemolytic Cytotoxic
10% Hemolysis | 3.18 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 34 Activity

Activity

IC50
Toxicity
2.05 µM
Cytotoxic
IC50 | 2.05 | µM | target cell: Human glomerular mesangial cells (GMC)

Target

Human glomerular mesangial cells (GMC)

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 35 Activity

Activity

10% Hemolysis
Toxicity
0.71 µM
Hemolytic Cytotoxic
10% Hemolysis | 0.71 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 36 Activity

Activity

IC50
Toxicity
1.37 µM
Cytotoxic
IC50 | 1.37 | µM | target cell: Human glomerular mesangial cells (GMC)

Target

Human glomerular mesangial cells (GMC)

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 37 Activity

Activity

10% Hemolysis
Toxicity
59.73 µM
Hemolytic Cytotoxic
10% Hemolysis | 59.73 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 38 Activity

Activity

IC50
Toxicity
164.3 µM
Cytotoxic
IC50 | 164.3 | µM | target cell: Human glomerular mesangial cells (GMC)

Target

Human glomerular mesangial cells (GMC)

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 39 Activity

Activity

10% Hemolysis
Toxicity
146.63 µM
Hemolytic Cytotoxic
10% Hemolysis | 146.63 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 40 Activity

Activity

10% Hemolysis
Toxicity
103.52 µM
Hemolytic Cytotoxic
10% Hemolysis | 103.52 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 41 Activity

Activity

10% Hemolysis
Toxicity
1.31 µM
Hemolytic Cytotoxic
10% Hemolysis | 1.31 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 42 Activity

Activity

IC50
Toxicity
1.69 µM
Cytotoxic
IC50 | 1.69 | µM | target cell: Human glomerular mesangial cells (GMC)

Target

Human glomerular mesangial cells (GMC)

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 43 Activity

Activity

10% Hemolysis
Toxicity
1.06 µM
Hemolytic Cytotoxic
10% Hemolysis | 1.06 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 44 Activity

Activity

IC50
Toxicity
1.28 µM
Cytotoxic
IC50 | 1.28 | µM | target cell: Human glomerular mesangial cells (GMC)

Target

Human glomerular mesangial cells (GMC)

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 45 Activity

Activity

10% Hemolysis
Toxicity
10.91 µM
Hemolytic Cytotoxic
10% Hemolysis | 10.91 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 46 Activity

Activity

IC50
Toxicity
2.36 µM
Cytotoxic
IC50 | 2.36 | µM | target cell: Human glomerular mesangial cells (GMC)

Target

Human glomerular mesangial cells (GMC)

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 47 Activity

Activity

10% Hemolysis
Toxicity
103.4 µM
Hemolytic Cytotoxic
10% Hemolysis | 103.4 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 48 Activity

Activity

IC50
Toxicity
31.89 µM
Cytotoxic
IC50 | 31.89 | µM | target cell: Human glomerular mesangial cells (GMC)

Target

Human glomerular mesangial cells (GMC)

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 49 Activity

Activity

10% Hemolysis
Toxicity
12.51 µM
Hemolytic Cytotoxic
10% Hemolysis | 12.51 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 50 Activity

Activity

IC50
Toxicity
2.73 µM
Cytotoxic
IC50 | 2.73 | µM | target cell: Human glomerular mesangial cells (GMC)

Target

Human glomerular mesangial cells (GMC)

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 51 Activity

Activity

10% Hemolysis
Toxicity
210.92 µM
Hemolytic Cytotoxic
10% Hemolysis | 210.92 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 52 Activity

Activity

IC50
Toxicity
116.32 µM
Cytotoxic
IC50 | 116.32 | µM | target cell: Human glomerular mesangial cells (GMC)

Target

Human glomerular mesangial cells (GMC)

Source & Reference

NA
DBAASP
Tuning the Activity of Anoplin by Dendrimerization of Lysine and Lipidation of the N-Terminal. | ACS Omega | 2021
Evidence 53 Activity

Activity

% Hemolysis
Toxicity
1 %
Hemolytic
Hemolytic_activity: [Ref.25316570] 1% hemolysis at 12.5 µg/ml , 2% hemolysis at 25 µg/ml , 1% hemolysis at 50 µg/ml , 1.5% hemolysis at 100 µg/ml , 1.5% hemolysis at 200 µg/ml against mice red blood cells.##[Ref.27862650]3% hemolysis at 100µg/ml , 6% hemolysis at 200µg/ml , 10% hemolysis at 300µg/ml , 12% hemolysis at 500µg/ml against human red blood cells

Target

erythrocytes

Source & Reference

NA
DRAMP
Peptides. 2018 Jun 104:7-14.##J Pept Sci. 2014 Dec 20(12):945-51. doi: 10.1002/psc.2705.##J Pept Sci. 2016 Nov 22(11-12):731-736. doi: 10.1002/psc.2939.
Evidence 54 Hemolysis

Source & Reference

APD_complete PD_Hemolysis
APD_complete PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation.